20-32798507-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 3P and 3B. PM2PP2BP4_ModerateBS1_Supporting

The ENST00000328111.6(DNMT3B):​c.1538C>T​(p.Ala513Val) variant causes a missense change. The variant allele was found at a frequency of 0.000478 in 1,614,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A513S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00051 ( 0 hom. )

Consequence

DNMT3B
ENST00000328111.6 missense

Scores

7
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1B:2

Conservation

PhyloP100: 4.89
Variant links:
Genes affected
DNMT3B (HGNC:2979): (DNA methyltransferase 3 beta) CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Eight alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq, May 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), DNMT3B. . Gene score misZ 1.5 (greater than the threshold 3.09). Trascript score misZ 3.3234 (greater than threshold 3.09). GenCC has associacion of gene with immunodeficiency-centromeric instability-facial anomalies syndrome, immunodeficiency-centromeric instability-facial anomalies syndrome 1.
BP4
Computational evidence support a benign effect (MetaRNN=0.08021927).
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.000506 (739/1461822) while in subpopulation EAS AF= 0.00232 (92/39700). AF 95% confidence interval is 0.00193. There are 0 homozygotes in gnomad4_exome. There are 348 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DNMT3BNM_006892.4 linkuse as main transcriptc.1538C>T p.Ala513Val missense_variant 15/23 ENST00000328111.6 NP_008823.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DNMT3BENST00000328111.6 linkuse as main transcriptc.1538C>T p.Ala513Val missense_variant 15/231 NM_006892.4 ENSP00000328547 A2Q9UBC3-1

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152244
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000963
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000215
AC:
54
AN:
250816
Hom.:
0
AF XY:
0.000236
AC XY:
32
AN XY:
135662
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000381
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.000380
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000506
AC:
739
AN:
1461822
Hom.:
0
Cov.:
31
AF XY:
0.000479
AC XY:
348
AN XY:
727206
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00232
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000560
Gnomad4 OTH exome
AF:
0.000282
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152362
Hom.:
0
Cov.:
33
AF XY:
0.000188
AC XY:
14
AN XY:
74500
show subpopulations
Gnomad4 AFR
AF:
0.000120
Gnomad4 AMR
AF:
0.0000653
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000965
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000309
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000347
Hom.:
0
Bravo
AF:
0.000193
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000214
AC:
26
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.000415

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Centromeric instability of chromosomes 1,9 and 16 and immunodeficiency Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 23, 2022This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 513 of the DNMT3B protein (p.Ala513Val). This variant is present in population databases (rs116943489, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with DNMT3B-related conditions. ClinVar contains an entry for this variant (Variation ID: 579562). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.22
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
T;.;.;.;.;.
Eigen
Uncertain
0.19
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Uncertain
0.96
D;D;D;D;D;D
M_CAP
Benign
0.054
D
MetaRNN
Benign
0.080
T;T;T;T;T;T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.4
L;.;.;.;.;.
MutationTaster
Benign
0.96
D;D;D;D;D;D;D;D
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-2.3
N;N;N;N;N;N
REVEL
Uncertain
0.34
Sift
Benign
0.32
T;T;T;T;T;T
Sift4G
Benign
0.50
T;T;T;T;T;T
Polyphen
0.87
P;P;D;.;.;P
Vest4
0.37
MVP
0.60
MPC
1.9
ClinPred
0.24
T
GERP RS
5.8
Varity_R
0.18
gMVP
0.56

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs116943489; hg19: chr20-31386313; API